- $416.08m
- $421.58m
- $824.50m
Brief: Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
Myriad Genetics Inc expected to post a loss of 10 cents a share - Earnings Preview
Myriad Genetics Inc expected to post a loss of 10 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snap One, Encore Wire, Centene
U.S. STOCKS ON THE MOVE-Cisco Systems, Inspired Entertainment, Spirit Airlines
U.S. RESEARCH ROUNDUP-Autozone, Constellation Energy, Sterling Infrastructure
Myriad Genetics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Myriad Genetics Q4 Operating Income USD -31.4 Million
Myriad Genetics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: Myriad Genetics Names George Daneker Jr., MD, As President And Chief Clinical Officer Of Oncology
Brief: Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
Brief: Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires Scott Leffler Appointed As Successor
Brief: Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform To Advance Patient Care
U.S. RESEARCH ROUNDUP- Carvana, Constellation Brands, CSG Systems International
Brief: Myriad Genetics And Personalis Partner To Market Solutions To Pharma Customers
U.S. STOCKS ON THE MOVE-Instacart, Nvidia, Novavax
U.S. STOCKS ON THE MOVE-Emeren Group, Tesla, Parker-Hannifin